Should we keep rocking? Portraits from targeting Rho kinases in cancer GR de Sousa, GM Vieira, PF das Chagas, JA Pezuk, MS Brassesco Pharmacological research 160, 105093, 2020 | 24 | 2020 |
miRNA signatures in childhood sarcomas and their clinical implications GM Viera, KB Salomao, GR De Sousa, M Baroni, LEA Delsin, JA Pezuk, ... Clinical and Translational Oncology 21, 1583-1623, 2019 | 19 | 2019 |
The therapeutic potential of Aurora kinases targeting in glioblastoma: from preclinical research to translational oncology T de Almeida Magalhães, GR de Sousa, G Alencastro Veiga Cruzeiro, ... Journal of Molecular Medicine 98, 495-512, 2020 | 17 | 2020 |
Ultraconserved long non-coding RNA uc. 112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia PF Chagas, GR Sousa, MH Kodama, CAO Biagi Junior, JA Yunes, ... Hematology, Transfusion and Cell Therapy 43, 28-34, 2021 | 16 | 2021 |
A coordinated approach for the assessment of molecular subgroups in pediatric ependymomas using low-cost methods GR de Sousa, RCP Lira, T de Almeida Magalhães, KR da Silva, ... Journal of Molecular Medicine 99 (8), 1101-1113, 2021 | 15 | 2021 |
MicroRNA dysregulation interplay with childhood abdominal tumors KB Salomão, JA Pezuk, GR de Souza, P Chagas, TC Pereira, ET Valera, ... Cancer and Metastasis Reviews 38, 783-811, 2019 | 15 | 2019 |
Notch pathway in ependymoma RELA-fused subgroup: upregulation and association with cancer stem cells markers expression T de Almeida Magalhães, GAV Cruzeiro, GR de Sousa, KR da Silva, ... Cancer Gene Therapy 27 (6), 509-512, 2020 | 12 | 2020 |
Perinatal complex low-and high-grade glial tumor harboring a novel GIGYF2-ALK fusion ET Valera, L Neder, RG Queiroz, AC Santos, GR Sousa, RS Oliveira, ... Pediatric blood & cancer 67 (1), e28015, 2020 | 9 | 2020 |
YM155 induces apoptosis in p53-deficient T-acute lymphoblastic leukemia cells independent of survivin inhibition L Sales, GR de Sousa, GÁ Ferreira-Silva, AM Castro-Gamero, M Ionta, ... Anti-Cancer Drugs 28 (3), 298-306, 2017 | 8 | 2017 |
Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies VF Oliveira, GR De Sousa, AC Dos Santos, FP Saggioro, HR Machado, ... Child's Nervous System 37, 375-382, 2021 | 6 | 2021 |
Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study AM Donson, KC Bertrand, KA Riemondy, D Gao, Y Zhuang, B Sanford, ... Neuro-oncology 25 (10), 1854-1867, 2023 | 5 | 2023 |
Activation of Hedgehog signaling by the oncogenic RELA fusion reveals a primary cilia-dependent vulnerability in supratentorial ependymoma T de Almeida Magalhães, G Alencastro Veiga Cruzeiro, ... Neuro-oncology 25 (1), 185-198, 2023 | 5 | 2023 |
Identification of ITPR1 as a Hub Gene of Group 3 Medulloblastoma and Coregulated Genes with Potential Prognostic Values PF das Chagas, GR de Sousa, LC Veronez, A Martins-da-Silva, ... Journal of Molecular Neuroscience, 1-9, 2022 | 5 | 2022 |
ADA2 deficiency (DADA2) associated with Evans syndrome and a severe ADA2 genotype MPL Ferriani, ET Valera, GR de Sousa, P Sandrin-Garcia, RR de Moura, ... Rheumatology 60 (7), e237-e239, 2021 | 5 | 2021 |
A novel type of C11orf95-LOC-RELA fusion in a grade II supratentorial ependymoma: report of a case with literature review GR de Sousa, SKN Marie, SM Oba-Shinjo, LNZ Ramalho, LG Tone, ... Child's Nervous System 35, 689-694, 2019 | 5 | 2019 |
Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas V Amani, KA Riemondy, R Fu, AM Griesinger, E Grimaldo, GR De Sousa, ... Acta Neuropathologica Communications 11 (1), 158, 2023 | 3 | 2023 |
Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors JAS Feitosa, PF das Chagas, GR de Sousa, RGP Queiroz, GAV Cruzeiro, ... Molecular Biology Reports 47, 6439-6443, 2020 | 3 | 2020 |
Full-house nephropathy associated with high expression of SPATA5L1 due to a genetic pathogenic variant LM De Carvalho, GR De Sousa, R Moura, F Saggioro, I Facincani, ... Rheumatology 61 (4), e84-e86, 2022 | 2 | 2022 |
YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells G Alencastro Veiga Cruzeiro, T de Almeida Magalhães, ... Cancers 13 (24), 6249, 2021 | 2 | 2021 |
The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma T de Almeida Magalhães, KS Borges, GR de Sousa, SR Brandalise, ... Neurological Sciences 41, 691-694, 2020 | 2 | 2020 |